- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07519083
Behavioral Health Referrals Study
Consumer-Therapist-Connector: Increasing Access to Quality Behavioral Healthcare
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The United States is experiencing a major mental health crisis. The gap between need and access to behavioral health services is rapidly increasing. Given that about ~50% of patients who have a behavioral health diagnosis will have had that condition first identified by a primary care physician (Hill et al., 2015; Reeves et al., 2011), the primary care setting is an ideal site to conduct an efficacy test of a new online behavioral health referral system called Express Access.
Stepped wedge cluster randomized trial (SW-CRT) is a preferred approach when it is difficult to randomize individual patients within a clinical practice (cluster) to a specific condition (e.g., Li & Wang, 2022). In this SW-CRT, all patients requesting, or recommended for, behavioral health referrals from their Primary Care Providers (PCPs) will be exposed to the Control condition (standard behavioral health referral processes) at the start of the study. Over time each PCP individual or practice (cluster) is randomized to a specific sequence (i.e., "step" or time point); all subsequent patients requesting a behavioral health referral will then be exposed to the Experimental condition (Express Access with TOP Match) at the beginning of the sequence to which each PCP was randomized.
RECRUITMENT PROCEDURES
The American Academy of Family Physicians (AAFP) will recruit PCPs from their membership to refer their patients to the study during routine visits (i.e., via verbal script or a flyer with a QR code linking to the consent form and study information).
METHODS AND PROCEDURES
Patients will review the study information by scanning the QR code provided by their PCP. Patients who sign the informed consent form will be sent weekly assessments (via email) until the patient reports that they found a therapist and scheduled an appointment. These assessments will ask about: how they searched for a therapist; satisfaction with the search method; challenges encountered during the search; confidence in finding a therapist within the next week (approximately 5-10 minutes per week). In addition, participants will complete the behavioral health well-being assessment (Treatment Outcome Package; TOP suite) at baseline and at one-month, two-month, and three-month intervals. The assessment includes demographic questions; questions about stressful life events, physical health, and medication use; ratings of behavioral health symptoms across 12 domains (approximately 10 minutes per assessment). PCPs will have access to this information to help connect the patient to a mental health provider. These data will remain confidential between the patient and their health treatment team to the extent allowed by law.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Framingham, Massachusetts, United States, 01701
- Outcome Referrals, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults seeking behavioral health referrals from licensed primary care providers.
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Express Access
|
Patients will access Express Access via a QR code on a flyer that their PCP will give them.
When they open the application, patients will be asked to select the name of the PCP who referred them and then complete a behavioral health assessment to help to identify therapists who treat patients with similar behavioral health needs.
|
|
No Intervention: Standard Referral Processes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant average score on the Clinical Scale of the Treatment Outcome Package (TOP-CS)
Time Frame: Baseline and a TOP-CS every month up to Month 3.
|
TOP is a comprehensive well-being assessment that is used in behavioral health settings.
The Adult TOP-CS is a 58-item scale for individuals aged 18 and over that assesses the client's past 2-week experience on 12 domains (e.g., quality of life, depression, anxiety, and suicidality).
The z-scores (standard deviation units relative to the general population mean for each domain) will be averaged together to create one summary score.
Higher scores suggest higher severity.
|
Baseline and a TOP-CS every month up to Month 3.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction score
Time Frame: Time Frame: Every week until the client makes an appointment with a therapist, maximum of 12 weeks
|
Satisfaction will be measured with this item: "How frustrated are you with the search methods you used during the past week compared to other things you have tried in the past?"
Response options are: 1=A lot more frustrated; 2=A little more frustrated; 3=No difference in frustration; 4=A little less frustrated; 5=Much less frustrated.
Scores range between 1 and 5 (higher scores indicate higher satisfaction).
|
Time Frame: Every week until the client makes an appointment with a therapist, maximum of 12 weeks
|
|
Number of days until first therapist appointment
Time Frame: Time Frame: Every week until the client makes an appointment with a therapist, maximum of 12 weeks)
|
Days between study start and report of first scheduled therapist appointment (fewer days indicate faster speed to treatment).
|
Time Frame: Every week until the client makes an appointment with a therapist, maximum of 12 weeks)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2R44MH132156-02 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Illness
-
Education University of Hong KongBaptist Oi Kwan Social ServiceCompletedSevere Mental IllnessHong Kong
-
New York UniversityUniversity of Pennsylvania; Yale UniversityCompleted
-
University of OklahomaCompleted
-
University of Illinois at ChicagoNational Institute on Disability, Independent Living, and Rehabilitation... and other collaboratorsCompletedMental Illness Persistent
-
Queen's UniversityCompletedSerious Mental Illness
-
McMaster UniversitySt. Joseph's Healthcare HamiltonNot yet recruitingSerious Mental IllnessCanada
-
Vrije Universiteit BrusselMondriaanNot yet recruitingMental Illness PersistentNetherlands
-
Temple UniversityRecruiting
-
Shalvata Mental Health CenterActive, not recruitingSevere Mental IllnessIsrael
-
King's College LondonSouth London and Maudsley NHS Foundation TrustCompletedSevere Mental IllnessUnited Kingdom
Clinical Trials on Express Access
-
Johns Hopkins UniversityNational Institute of Nursing Research (NINR)Completed
-
University of TorontoCompleted
-
VivaQuantCompletedAtrial Fibrillation (Paroxysmal) | Obstructive Sleep Apnea (OSA) | PalpitationsUnited States
-
NestléCompleted
-
Rhode Island HospitalCompleted
-
Boston Scientific CorporationCompletedAtherosclerotic Lesions in the Aortorenal OstiumUnited States
-
Children's Hospital Medical Center, CincinnatiChildren's Hospital Colorado; Nationwide Children's Hospital; MetroHealth Medical... and other collaboratorsCompletedTraumatic Brain InjuryUnited States
-
Medical University of ViennaCompleted
-
New York Head & Neck InstituteOhio State University; Biolase IncCompleted